Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma

由 Russo, Irene, Zorzetto, Ludovica, Chiarion Sileni, Vanna, Alaibac, Mauro
發表在 Scientifica (Cairo) (2018)

Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib

由 Valpione, Sara, Campana, Luca G., Pigozzo, Jacopo, Chiarion-Sileni, Vanna
發表在 Radiol Oncol (2015)

Systemic treatments for metastatic cutaneous melanoma

由 Pasquali, Sandro, Hadjinicolaou, Andreas V, Chiarion Sileni, Vanna, Rossi, Carlo Riccardo, Mocellin, Simone
發表在 Cochrane Database Syst Rev (2018)

Predictors of toxicity for metastatic melanoma patients treated with ipilimumab

由 Valpione, Sara, Pasquali, Sandro, Campana, Luca, Mocellin, Simone, Piccin, Luisa, Pigozzo, Jacopo, Chiarion-Sileni, Vanna
發表在 J Immunother Cancer (2015)

Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade

由 Valpione, Sara, Pasquali, Sandro, Campana, Luca Giovanni, Piccin, Luisa, Mocellin, Simone, Pigozzo, Jacopo, Chiarion-Sileni, Vanna
發表在 J Transl Med (2018)

Melanoma M (Zero): Diagnosis and Therapy

由 Rastrelli, Marco, Alaibac, Mauro, Stramare, Roberto, Chiarion Sileni, Vanna, Montesco, Maria Cristina, Vecchiato, Antonella, Campana, Luca Giovanni, Rossi, Carlo Riccardo
出版 2013

Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin’s Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study

由 Boldrin, Elisa, Rumiato, Enrica, Fassan, Matteo, Cappellesso, Rocco, Rugge, Massimo, Chiarion-Sileni, Vanna, Ruol, Alberto, Alfieri, Rita, Cagol, Matteo, Castoro, Carlo, Amadori, Alberto, Saggioro, Daniela
發表在 PLoS One (2015)

Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-g...

由 Chiarion-Sileni, Vanna, Del Bianco, Paola, Romanini, Antonella, Guida, Michele, Paccagnella, Adriano, Dalla Palma, Maurizio, Naglieri, Emanuele, Ridolfi, Ruggero, Silvestri, Barbara, Michiara, Maria, De Salvo, Gian Luca
出版 2006

A gene expression signature associated with survival in metastatic melanoma

由 Mandruzzato, Susanna, Callegaro, Andrea, Turcatel, Gianluca, Francescato, Samuela, Montesco, Maria C, Chiarion-Sileni, Vanna, Mocellin, Simone, Rossi, Carlo R, Bicciato, Silvio, Wang, Ena, Marincola, Francesco M, Zanovello, Paola
出版 2006

Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma

由 Valpione, Sara, Moser, Justin C., Parrozzani, Raffaele, Bazzi, Marco, Mansfield, Aaron S., Mocellin, Simone, Pigozzo, Jacopo, Midena, Edoardo, Markovic, Svetomir N., Aliberti, Camillo, Campana, Luca G., Chiarion-Sileni, Vanna
發表在 PLoS One (2015)

Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial

由 Maio, Michele, Grob, Jean-Jacques, Aamdal, Steinar, Bondarenko, Igor, Robert, Caroline, Thomas, Luc, Garbe, Claus, Chiarion-Sileni, Vanna, Testori, Alessandro, Chen, Tai-Tsang, Tschaika, Marina, Wolchok, Jedd D.
發表在 J Clin Oncol (2015)

PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esopha...

由 Fassan, Matteo, Cavallin, Francesco, Guzzardo, Vincenza, Kotsafti, Andromachi, Scarpa, Melania, Cagol, Matteo, Chiarion‐Sileni, Vanna, Maria Saadeh, Luca, Alfieri, Rita, Castagliuolo, Ignazio, Rugge, Massimo, Castoro, Carlo, Scarpa, Marco
發表在 Cancer Med (2019)

Prognostic Factors in Merkel Cell Carcinoma: A Retrospective Single-Center Study in 90 Patients

由 Rastrelli, Marco, Ferrazzi, Beatrice, Cavallin, Francesco, Chiarion Sileni, Vanna, Pigozzo, Jacopo, Fabozzi, Alessio, Tropea, Saveria, Vecchiato, Antonella, Costa, Alessandra, Parisi, Alessandro, Rossi, Carlo Riccardo, Del Fiore, Paolo, Alaibac, Mauro
發表在 Cancers (Basel) (2018)

Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity

由 Turato, Cristian, Scarpa, Melania, Kotsafti, Andromachi, Cappon, Andrea, Quarta, Santina, Biasiolo, Alessandra, Cavallin, Francesco, Trevellin, Elisabetta, Guzzardo, Vincenza, Fassan, Matteo, Chiarion‐Sileni, Vanna, Castoro, Carlo, Rugge, Massimo, Vettor, Roberto, Scarpa, Marco, Pontisso, Patrizia
發表在 Cancer Sci (2019)

The cost of unresectable stage III or stage IV melanoma in Italy

由 Maio Michele, Ascierto Paolo, Testori Alessandro, Ridolfi Ruggero, Bajetta Emilio, Queirolo Paola, Guida Michele, Romanini Antonella, Chiarion-Sileni Vanna, Pigozzo Jacopo, Di Giacomo Anna Maria, Calandriello Mario, Didoni Guido, van Baardewijk Marck, Konto Cyril, Lucioni Carlo
出版 2012-11-01

The cost of unresectable stage III or stage IV melanoma in Italy

由 Maio, Michele, Ascierto, Paolo, Testori, Alessandro, Ridolfi, Ruggero, Bajetta, Emilio, Queirolo, Paola, Guida, Michele, Romanini, Antonella, Chiarion-Sileni, Vanna, Pigozzo, Jacopo, Di Giacomo, Anna Maria, Calandriello, Mario, Didoni, Guido, van Baardewijk, Marck, Konto, Cyril, Lucioni, Carlo
出版 2012

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme

由 Altomonte, Maresa, Di Giacomo, Anna Maria, Queirolo, Paola, Ascierto, Paolo Antonio, Spagnolo, Francesco, Bajetta, Emilio, Calabrò, Luana, Danielli, Riccardo, de Rosa, Francesco, Maur, Michela, Chiarion-Sileni, Vanna, Ferrucci, Pier Francesco, Giannarelli, Diana, Testori, Alessandro, Ridolfi, Ruggero, Maio, Michele
出版 2013

A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients

由 Rastrelli, Marco, Del Fiore, Paolo, Buja, Alessandra, Vecchiato, Antonella, Rossi, Carlo Riccardo, Chiarion Sileni, Vanna, Tropea, Saveria, Russano, Francesco, Zorzi, Manuel, Spina, Romina, Cappellesso, Rocco, Mazzarotto, Renzo, Cavallin, Francesco, Bassetto, Franco, Bezzon, Elisabetta, Ferrazzi, Beatrice, Alaibac, Mauro, Mocellin, Simone
發表在 Front Oncol (2020)

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

由 Queirolo, Paola, Spagnolo, Francesco, Ascierto, Paolo Antonio, Simeone, Ester, Marchetti, Paolo, Scoppola, Alessandro, Del Vecchio, Michele, Di Guardo, Lorenza, Maio, Michele, Di Giacomo, Anna Maria, Antonuzzo, Andrea, Cognetti, Francesco, Ferraresi, Virginia, Ridolfi, Laura, Guidoboni, Massimo, Guida, Michele, Pigozzo, Jacopo, Chiarion Sileni, Vanna
出版 2014

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized...

由 Schadendorf, Dirk, Wolchok, Jedd D., Hodi, F. Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C. Lance, Lao, Christopher D., Chesney, Jason, Robert, Caroline, Grossmann, Kenneth, McDermott, David, Walker, Dana, Bhore, Rafia, Larkin, James, Postow, Michael A.
發表在 J Clin Oncol (2017)